AGC Biologics to Prepare Late Phase and Commercial Runs for Immunocore
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Dieter Kramer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AGC Biologics has completed the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at Heidelberg, Germany.
Global CDMO’s Heidelberg Facility Supplies more pDNA material to help address growing needs...
Global CDMO's Heidelberg Facility Supplies more pDNA material to help address growing needsHeidelberg, Germany, Feb. 08, 2022, a leading global Biopharmaceutical Contract Development and Manufacturing
Investegate announcements from AGC Biologics, AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material